Form D · Pharmaceuticals
VistaGen Therapeutics, Inc.
South San Francisco, CA · CIK 0001411685
Offering snapshot reported Feb 21, 2023 · SEC filing
- Reported sold
- $0 Offering amount: $2.8M
- Investors reported
- 129 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 2, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 21, 2023 | Initial | $0 | No comparison | 129 | SEC filing |
| Jan 31, 2020 | Initial | $2,750,000 | No comparison | 3 | SEC filing |
| Dec 12, 2019 | Initial | $650,000 | No comparison | 7 | SEC filing |
| Sep 21, 2018 | Initial | $4,778,750 | No comparison | 33 | SEC filing |
| Aug 22, 2017 | Initial | $1,037,750 | No comparison | 14 | SEC filing |
| Aug 6, 2015 | Initial | $1,930,281 | No comparison | 15 | SEC filing |
| Jun 30, 2014 | Initial | $1,570,000 | No comparison | 21 | SEC filing |
| Mar 7, 2012 | Initial | $500,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-473834
Source: Form D, filed Feb 21, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Reid G. Adler | Executive |
| Gregory A. Bonfiglio | Director |
| Underdown J. Brian | Director |
| Ann M. Cunningham | Director |
| Joanne Curley | Director |
| Jerrold D. Dotson | Executive |
| Margaret M. Fitz Patrick | Director |
| Jerry B. Gin | Director |
| Mark A. Mc Partland | Executive |
| A. Franklin Rice | Executive |
| Mary L. Rotunno | Director |
| Jon S. Saxe | Director |
| Shawn K. Singh | Director, Executive |
| Mark A. Smith | Executive |
| H. Ralph Snodgrass | Director, Executive |
| Brian J. Underdown | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
343 Allerton Avenue
South San Francisco, CA, 94080
South San Francisco, CA, 94080